BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | 14.31% | -14.01% | 1.30% | -1.22% | -56.32% |
| Total Depreciation and Amortization | 8.20% | -14.84% | -29.40% | -45.60% | -36.12% |
| Total Amortization of Deferred Charges | -26.55% | -37.32% | -41.29% | -44.24% | -37.22% |
| Total Other Non-Cash Items | 82.37% | 62.37% | 5,180.73% | 3,032.03% | 2,386.41% |
| Change in Net Operating Assets | -105.50% | 122.23% | -290.59% | -750.41% | -28.16% |
| Cash from Operations | 36.68% | 25.30% | 11.50% | 21.52% | -41.09% |
| Capital Expenditure | 72.93% | -- | -- | 94.44% | -10.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -98.71% | -- |
| Cash from Investing | 72.93% | -- | -- | -98.84% | -100.91% |
| Total Debt Issued | -- | -88.84% | -- | -- | -- |
| Total Debt Repaid | 0.00% | -7.54% | -26.64% | -14.88% | 1.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 81.35% | -2.66% | -- | -- |
| Cash from Financing | 1,764.72% | -91.34% | -2.96% | 7.29% | 20.58% |
| Foreign Exchange rate Adjustments | 30.91% | -- | -- | 100.00% | 5,600.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.42% | -110.95% | 10.83% | -2,252.06% | -454.04% |
